Perturba Therapeutics

A Cyclica spin out from the Stagljar Lab at the University of Toronto, Donnelly Centre, Perturba is advancing a rich pipeline of assets from undrugged protein-protein interactions (PPIs). Perturba integrates Cyclica’s AI-augmented drug discovery platform with sensitive, live-cell drug screening assays from the Stagljar lab.